Brief: Rakuten Medical: Closes $119 Million Series E Financing To Develop Alluminox™ Platform, Including $45 Million In New Capital And Conversion Of $74 Million Of Convertible Promissory Notes With Accrued Interest
07/03/2024 01:52
March 7 (Reuters) - Rakuten Group Inc 4755.T :
* RAKUTEN MEDICAL: CLOSES $119 MILLION SERIES E FINANCING TO
DEVELOP ALLUMINOX™ PLATFORM, INCLUDING $45 MILLION IN NEW
CAPITAL AND CONVERSION OF $74 MILLION OF CONVERTIBLE PROMISSORY
NOTES WITH ACCRUED INTEREST
* RAKUTEN MEDICAL: SERIES E INVESTORS INCLUDE UK-BASED
PHARMACEUTICAL COMPANY HIKMA, MIZUHO BANK, DAI-ICHI LIFE, SBI
GROUP, RAKUTEN GROUP AND ITS CEO MIKITANI
Source text: https://rakuten-med.com/us/news/press-releases/2024/03/06/7827/
Further company coverage: 4755.T
(Reporting by Kantaro Komiya)
((Kantaro.Komiya@thomsonreuters.com;))
Recent news on Rakuten
See all newsBrief: Rakuten Travel - Overseas Hotel Booking Site And Multilingual Booking Site Suffered Unauthorized Access, Up To 2.6 Million Customer Records Exposed In The Breach
Brief: Ferrari Signs Partnership Deal With Rakuten
German drone maker Helsing enlists Rakuten to broker Japan military deal
Brief: Rakuten Group To Partner With German Defence Startup Helsing, Nikkei Reports
Recorded Impairment Loss On Fixed Assets Of 17 Billion Yen In Q2